Actos Recall | Actos Lawyer

Widow Files Actos Lawsuit on Behalf of Deceased Husband

Staff Writer | November 21st, 2011

The French Actos recall issued in June 2011, which warned of the risk of Actos bladder cancer, was cited in a recent Actos bladder cancer lawsuit filed in the United States District Court of the Eastern District of New York by an Actos lawyer.

On November 8, 2011, Linda Sawyer and her Actos lawyer filed suit against Takeda Pharmaceuticals on behalf of her deceased husband, Gary Sawyer. Gary Sawyer took Actos to help treat his Type 2 diabetes from 2006 to 2009 — several years previous to the Actos recall in Europe. In June 2008, he contracted Actos bladder cancer. After his death on Nov. 10, 2009, Linda Sawyer hired an Actos lawyer to seek damages for her husband’s illness and death.

Actos lawyer alleges Actos bladder cancer

Linda Sawyer alleges that despite scientific information linking the diabetes drug to Actos bladder cancer, Takeda never informed consumers about the risk. In fact, she and her Actos lawyer allege that the company intentionally hid its knowledge about the potentially deadly Actos bladder cancer — the cause of the 2011 French Actos recall — resulting in inadequate labeling and health warnings. Sawyer and her Actos lawyer use information from a study that led to the French Actos recall to support their claim.

Sawyer also filed suit against Takeda on her own behalf. She and her Actos lawyer claim that the company owes her compensation for depriving her of the comfort and enjoyment of her husband’s company. Judge Leonard D. Wexler is reviewing the case brought by Sawyer and her Actos lawyer.

European countries issue Actos recall

No Actos recall has been issued in the United States, but that’s not the case in France, where the diabetes drug was banned in June 2011 after a study was published not only linking Actos to bladder cancer, but also showing an increased risk for Actos bladder cancer in those who used the drug for more than one year.

As an expert Actos lawyer knows, the French Actos recall ignited anti-Actos sentiments in Europe. That same month, the European Medicine Agency suspended the drug, while Germany’s Federal Institute for Drugs and Medical devices also issued an Actos recall. The FDA, meanwhile, demanded changes to the Actos warning label and suggested that because of the risk of Actos bladder cancer, doctors refrain from prescribing the drug to individuals with a personal history of the disease.

Injured patients continue to hire an Actos lawyer

After the Actos recall in France, there was an increase in the number of Actos bladder cancer lawsuits filed in the U.S.. Now potential plaintiffs and their Actos lawyer are speculating as to whether multidistrict litigation (MDL) will be created to manage the influx of cases alleging not only Actos bladder cancer, but also Actos heart failure.

The U.S. Judicial Panel on Multidistrict Litigation is expected to hold a hearing on the possibility of joining together lawsuits filed by an Actos lawyer across the country into MDL in December, 2011. At this point, an Actos lawyer can only speculate as to how a future FDA Actos recall would impact litigation.